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Population-Based Analysis of Venous Thrombotic Events Following
Saphenous Ablation
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L.A. Killewich, University of Texas Medical Branch, Galveston, Tex
Background: Venous thrombotic events following great and small
saphenous vein ablation procedures for varicose veins have been reported.
Current knowledge of these events is based on single institution studies with
small sample sizes.
Methods: The National Surgical Quality Improvement Program
(NSQIP) database (2005-2009) was used to identify a total of 3,874
patients who underwent radiofrequency ablation (RFA) or endovenous laser
ablation (EVLA) of the great and small saphenous veins with or without stab
phlebectomy. Outcome variables included clinically documented postoperative
deep vein thrombosis (DVT) or pulmonary embolism (PE). Bivariate and
multivariate logistic regression analyses were performed to identify factors
associated with venous thrombotic events after ablation procedures.
Results: A total of 2,897 (74.8%) patients underwent RFA and 977
(25.2%) underwent EVLA for lower extremity varicose veins. Patients who
underwent RFA were more likely to be older (53.8 y vs 51.8 y, P.0001),
obese (42.8% vs 38%, P.009), diabetic (8.5% vs 6.4%, P.01) hypertensive
(31.9% vs 26.8%, P.002) and to have undergone procedures involving
both veins (24% vs 4%, P.0001). Patients who underwent EVLA were
more likely to have received general anesthesia (56.9% vs 40.8%, P.0001),
to have undergone concomitant stab phlebectomy (44.9% vs 31.7%,
P.0001), and had longer operative times (63.6 min vs. 57.3 min,
P.0001). The incidence of DVT (1.74% vs 1.52%, P.63) and pulmonary
embolus (0.07% vs 0%, P1) were similar between EVLA and RFA. No
significant predictors of DVT in the postoperative period were identified on
bivariate or multivariate analyses. In the subgroup of patients who under-
went ablation procedures only (no stab phlebectomy, N2514), there was
a trend toward higher incidence of DVT in patients undergoing EVLA (2.6%
vs 1.4%, P.057). After adjusting for patient demographics, patients pre-
senting with lower extremity ulcers were 2.4 times more likely to develop
DVT compared to those without ulcers (OR2.4, 95% CI1.01-6.11,
P.04). In the multivariate model when only ablation procedures were
performed, EVLA was associated with an 83% increase in odds of DVT
compare to RFA, although not statistically significant (OR1.83, 95% CI
0.95-3.52, P.06).
Conclusions: The incidence of venous thrombotic events after saphe-
nous ablation is low. However, given that patients with lower extremity
ulcers experienced an increased risk of DVT, care should be taken to ensure
that the ablation catheter is positioned an appropriate distance from the
sapheno-femoral or sapheno-popliteal junction, and postprocedural preven-
tative measures such as early ambulation and lower extremity compression
should be emphasized. The finding of a trend toward increased venous
thrombotic events in patients undergoing EVLA warrants further investiga-
tion in a large patient population.
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Background: The incidence of varicose veins is similar among older
male and female subjects. Given that estrogen receptors (ERs) have a
significant vasodilator effect in various arterial preparations, we hypothesized
that ERs may mediate venous dilation in the setting of varicose veins. We
have recently shown that estrogenic compounds induce relaxation of rat
inferior vena cava in an ER subtype-specific fashion. This study was designed
to test whether specific ERs mediate relaxation in human veins, and whether
ER-mediated activity and vein relaxation are enhanced in varicose veins.
Methods: Specimens of greater saphenous vein from male patients
(average 69 years old) undergoing lower extremity bypass (n5) were used
as control veins. Varix segments were obtained from male patients (average
56 years old) undergoing varicose vein stripping (n6). Circular vein
segments were equilibrated under 2 g of tension in a tissue bath containing
Krebs solution, bubbled with 95% O2 5% CO2, at 37°C, and the changes in
isometric contraction were recorded. Vein segments were precontracted
with 96 mMKCl depolarizing solution or the -adrenergic receptor agonist
phenylephrine (Phe 105 M). To test for the specific ER, vein segments
were treated with increasing concentrations (1012 to 105 M) of 17
-
estradiol (E2, activator of most ERs), PPT (ER agonist), DPN (ER

agonist), and G1 (GPR30 agonist), and the % venous relaxation was re-
corded.
Results: In control veins, ER agonists caused a small concentration-
dependent relaxation of KCl contraction that reached amaximum at 105M
[E2 (15.936.44)  DPN (15.286.23)  PPT (13.934.20)  G1
(7.973.73)]. ER agonists-induced relaxation of KCl contraction was not
different or only slightly greater in varicose veins [E2 (19.694.75) PPT
(19.763.02)  G1 (17.732.07)  DPN (15.244.36)]. Compared to
the relaxation of KCl contraction, ER agonists caused greater relaxation of
Phe contraction in control veins [E2 (25.005.66) PPT (25.095.90)
DPN (19.568.90) G1 (13.688.26)]. In comparison, the ER agonists
caused significantly greater relaxation of Phe contraction in varicose veins
[E2 (50.768.16)  DPN (51.118.69)  PPT (46.6810.69)  G1
(42.306.98)].
Conclusion: In control veins, ER agonists cause small relaxation of
KCl-induced contraction, suggesting some inhibition of Ca2 entry
through voltage-gated channels; and greater relaxation of Phe contraction,
suggesting inhibition of additional receptor-operated Ca2 channels or
Ca2-sensitization mechanisms. In varicose veins, ER agonists cause mark-
edly greater relaxation of Phe, but not KCl, contraction, suggesting greater
expression/activity of ER and enhanced post-ER inhibitory effects on
receptor-operated Ca2 channels or Ca2-sensitization mechanisms, lead-
ing to less contractile and more distensible veins, and thereby possibly
account for the increased venous dilation associated with varicose veins.
Which is More Important for Postoperative Recovery: Laser Wave-
length or Fibers?
L.S.K. Kabnick, New York University, New York, NY
Background: Rapid progression in technique and technology has
characterized the growth of endovenous laser ablation since its inception.
Moreover, the treatment parameters that have demonstrated significance in
altering patient outcomes including: power, wavelength, linear endovenous
energy density (LEED), and type of fiber-tip. Postoperative outcomes
concerning pain and bruising have been attributed to vein wall perforation.
This study presents an in-vitro method to quantify the potential for pain and
bruising by comparing the degree of perforation of vessels with regard to
wavelength and fibers.
Table I. Results 1.
Group Laser Power Leeds Fiber N Mean SD
C1 810nm 14W 80J/cm BT 12 19.0% 12.5%
C2 810nm 14W 80J/cm JT 12 2.09% 7.25%
C3 1470nm 6W 42J/cm BT 12 16.6% 14.6%
C4 1470nm 6W 42J/cm JT 12 1.94% 3.39%
Table II. Results 2.
Comparison Mean difference 95% CI for difference P value
Groups
G1 vs G2 16.9% 8.11, 25.69 .001
G1 vs G3 2.40% 9.12, 13.92 .669
G1 vs G4 17.05% 8.91, 25.81 .001
G2 vs G3 14.50% 24.45, 4.54 .007
G2 vs G4 0.15% 4.77, 5.07 .95
G3 vs G4 14.65% 5.23, 24.06 .005
Methods:Adirect comparisonwas performedusing 810nmand1470nm
diode lasers at clinically relevant treatment parameters in combinationwith Bare
Tip (BT) vs. Jacketed Tip (JT) fibers. Cohorts of 12 samples each were tested
encompassing 810nm/BT Fiber, 810nm/JT Fiber, 1470nm/BT Fiber, and
1470nm/JT Fiber. Simulated veins with a thickness of 0.5 mmwere staked on
a gelatin base. The fibers were attached to amotorized slide and oriented so the
fiber tip was in contact and parallel to the vein throughout each test run. The
assembly was covered with sheep blood to a depth of 2 - 3 mm. The pullback
slide and laserwere started simultaneously, pulling fibers over the vein at set rates
to achieve the desired LEEDs. The lengths of all perforations within a vein
segment were measured, added together and divided by the vein length to
obtain the percent length of perforation.
Results: The results show the degree of perforation for each test group
along with the t-test statistical analysis between groups. (See Tables I and II)
The actual treatment lengths had a mean of 61.6mm  5.4mm. There was
no significant difference between the groups of vessel lengths.
Conclusions: Surprisingly, neither wavelength was superior when
comparing like fibers in degree of perforations. However, jacketed tip fibers
demonstrated a significantly lower degree of perforation compared to bare
tip fibers with either the 810 or 1470 nm lasers at standard clinical param-
eters. This in vitro study suggests that jacketed tip fibers are superior in terms
of postoperative recovery limiting pain and bruising.
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